Sessions

1st Day

Presentation Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
18:00 - 18:40 40 KSIC 2018 Reception
Opening Remark
Dinner
18:40 - 20:00 80 Hot Topic of Research Group

2nd Day

Main Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:05 65 K-VIS : Endovascular Aortic Repair Controversies
12/4 Fenestrated/Branch and Chimney TEVAR
12/4 TEVAR for Aortic Dissection
12/4 Complex Endoleak Management - Existing and Emerging Methods
12/4 New Grafts and Flow-Modulating Stents for EVAR
09:05 - 10:35 90 TSCI-KSIC Joint Session : TAVR
15 KSIC : Korean TAVR Registry
15 TSCI : Combination of Proglide and Angio-Seal for Femoral Access Hemostasis in Transcatheter Aortic Valve Replacement
15 KSIC : Minimizing the Need for Permanent Pacemakers
15 TSCI : Transcatheter Valve Replacement in Patients with Previous Cardiac Surgery
15 KSIC : TAVR in Bicuspid Aortic Valve
15 Discussion
10:35 - 11:40 65 KBC : Bifurcation Lesions - How to Treat Session
12 How to Treat Calcified Bifurcation Lesion
12 How to Treat Bifurcation Culprit Lesion in the Setting of Primary PCI
12 How to Treat Medina 001 Lesion
12 How to Treat True Bifurcation Lesion with Wide Bifurcation Angle
17 Discussion
11:40 - 12:45 65 Acute Coronary Syndrome
12 How Can We Predict ACS Occurrence in Future?: Non-invasive and Invasive Modalities
12 Managing Dilemmas in ACS Patients : Ischemia and Bleeding
12 Optimal Timing of Complete Revascularization in ACS Patients with Multivessel Disease
12 What Can We Do More for ACS Patients Other than PCI and Medication?
17 Discussion
12:45 - 13:50 65 Luncheon Symposium 1
13:50 - 14:10 20 Coffee Break
14:10 - 14:50 40 Moderated Abstract Poster Session @ Poster Zone
14:50 - 15:55 65 Expert Opinion Session
25 TBD
25 TBD
15 Discussion
15:55 - 17:00 65 Complex PCI: Treating Complex and Higher-Risk Indicated Patients (CHIP)
10 Transradial vs. Transfemoral Approach in CHIP
10 Hemodynamic Support: When and How?
10 Complete Revascularization vs. Culprit-only Revascularization in Patients with Cardiogenic Shock
10 Prevention of Acute Kidney Injury: What’s New?
10 Optimal Medical Treatment after PCI in Diabetic Patients
15 Discussion
17:00 - 18:05 65 정책세션
급성심근경색증 환자의 의료 접근성
12 급성심근경색증 환자 의료기관 접근성 (이용률)
12 심혈관질환 사망률 지역별 격차 (HIRA data)
12 지방 응급센터 급성심혈관질환 사각지대
12 심뇌혈관 응급전문의료체제 구축
17 Discussion
18:05 - 18:30 25 Healing Session
18:30 - Closing of Day 2
Symposium Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:05 65 IPOP: Reestablishing the Current Issues of FFR
12 Current Cut-point of FFR (0.8) Is Reliable to Predict Clinical Outcomes? What Is the Cut-point of FFR-guided PCI Benefit?
12 What Is Affecting FFR Value beyond Epicardial Stenosis?
12 When and Where Can We Apply FFR in ACS?
12 What Is an Additional Advantage to Measure Microvascular Function with FFR?
17 Discussion
09:05 - 10:10 65 SFR : Contemporary DES and BRS Issues
12 Biodegradable Polymer vs. Durable Polymer DES
12 Pathologic Aspects of Contemporary DES and BRS
12 Drug-coating Balloon vs. Re-stenting for the Treatment of ISR
12 How to Prevent Early and Late BRS Failure?
17 Discussion
10:00 - 11:15 65 PRG : The Issues Regarding the Recent Hot Trials
15 My Practice Following COMPASS
15 Validation of Current Bleeding Score Systems
15 Clinical Implication of TROPICAL-ACS
20 Discussion
11:15 - 12:45 90 CCT-KSIC : CTO
15 KSIC : When Should I Attempt A Retrograde CTO PCI?
15 CCT : How to Negotiate Complex Collateral Channel
15 KSIC : Possible Complications during the CTO Procedure and how to Solve Them
15 CCT : The Experience and Indication of Bridge-point Device in Japan
15 KSIC : The Importance of Imaging during CTO Intervention and How to Utilize It
15 Discussion
12:45 - 13:50 65 Luncheon Symposium 2
13:50 - 14:10 20 Coffee Break
14:10 - 14:50 40 Moderated Abstract Poster Session @ Poster Zone
14:50 - 15:55 65 K-CTO : Antegrade CTO PCI - Specific Consideration
12/4 All the CTA Can Do for CTO (Which Approach Is Preferred?)
12/4 Basic Preparation for the Successful Anterograde PCI
12/4 What Should Be Different in Retry Antegrade CTO
12/4 How to Overcome Heavy Calcified CTO Lesion for the Successful Anterograde PCI?
15:55 - 17:00 65 Women Heart: Unsettled Issues and Future Direction of CVD Management in Women
10 Non-obstructive Coronary Disease and Clinical Prognosis in Women
10 Sex Differences in Plaque Characteristics of ACS
10 Impact of Female Gender on Bleeding Complications and Antithrombotic Management
10 Female Gender and Clinical Outcomes of Patients with AMI
10 Risk Modification and Prevention for CV Events in Women
15 Discussion
17:00 - 18:05 65 Video Live : Taped Case Presentation - From Preprocedural Planning to the Closure
12 ASD / PFO Closure Case
12 LAAO Case
12 PMV Case
12 Aortic Disease
17 Discussion
18:05 - 18:30 25 Healing Session
18:30 - Closing of Day 2
Presentation Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:05 65 BRS, DES, and DEB : Where are they? - Focused on Clinical Evidence
10 BRS : History of BVS: From Cradle to Grave
10 BRS : To Metal Based
10 DES : From Durable Polymer
10 DES : To Biodegradable Polymer
10 DEB : Is There Room for DEB?
15 Discussion
09:05 - 10:10 65 Case Presentation 1 - Coronary
10:10 - 11:15 65 Innovation in CV field
12 Telemedicine in CV Fields
12 Wearable Devices in CV Fields
12 Big Data, How to Change Our Fields?
12 Current Status of Remote Angiogram System
17 Discussion
11:15 - 12:45 90 K-TRI : Tranradial and Transfemoral - Focused Lectures
15/7 Transradial Access and the Risk of Periprocedural Stroke: Comparison of Transradial and Transfemoral Access Site
15/7 Radial Artery Occlusion after Transradial Catheterization
15/7 Use of Slender Sheaths for Complex PCI
15/7 Same-day Discharge after Transradial Coronary Intervention: Is There Any Benefits?
12:45 - 13:50 65 Luncheon Symposium 3
13:50 - 14:10 20 Coffee Break
14:10 - 14:50 40 Moderated Abstract Poster Session @ Poster Zone
14:50 - 15:55 65 K-CCC : Device Related Complication- Coronary Artery Disease
12 Case : BioResorbable Vascular Scaffold
12 Case : Rotablator
12 Case : Balloon
17 Discussion
12 Summary Lecture : How to Make My Lab Prepared for Emergent Complicated Situation
15:55 - 17:25 90 Case Presentation 2 - Non Coronary
18:05 - 18:30 25 Healing Session
18:30 - Closing of Day 2

3rd Day

Main Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:30 90 K-CCC : Device Related Complication-Structural Heart Disease, Peripheral Arterial Disease
10/5 Case : TAVR Prosthesis
10/5 Case : LA Appendage Closing Devices
10/5 Case : ASD Closing Devices
10/5 Case : Aortic Endograft
10/5 Case : Peripheral Atherectomy Device
15 Summary Lecture : TAVR Related Complication
09:30 - 11:00 90 Lectures from Opinion Leaders
11:00 - 11:30 30 KSIC General Meeting
11:30 - 12:35 65 K-TRI : Transradial Intervention in Special Situation - Case-oriented Lectures
10/6 Case-oriented Lecture: Transradial Intervention for Bifurcation Lesion
10/6 Case-oriented Lecture: Transradial Carotid Angiography and Invervention
10/6 Case-oriented Lecture: Transradial Intervention for Ectatic Vessel Using OCT
10/6 Case-oriented Lecture: Transradial Intervention for STEMI Patients
12:35 - 13:40 65 Luncheon Symposium 4
13:40 - 15:10 90 CVIT-KSIC Joint Session : DAPT and Beyond
15 KSIC : Current Guidelines for DAPT
15 CVIT :
15 KSIC : Stop Aspirin Strategy after DAPT
15 CVIT :
15 KSIC : VKA Alone after 1 year in AF ? Is It Enough?
15 Discussion
15:10 - 16:40 90 KBC : Bifurcation Lesions- Updated Insight
13/5 Plaque Shift vs Carina Shift: Which Is It, and Does It Matter?
13/5 How to Optimize Bifurcation PCI with Invasive Imaging?
13/5 Trends & Outcomes of Non-LM & LM Bifurcation Lesion
13/5 Contemporary Bifurcation PCI Techniques: Step-by-Step Lessons from Expert
13/5 Technical Issues for Bifurcation PCI: Predilation, FKB, POT, and re-POT
16:40 - Closing of Day 3
Symposium Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:30 90 CIT-KSIC Joint Session : BRS
Bioresorbable Vascular Scaffolds: Will it be Refined or Gone
15 KSIC : Current Status of BVS in Korea and Global
15 CIT :
15 KSIC : Incidence, Mechanisms and Predictors of Scaffold Failure
15 CIT :
15 KSIC : What about New Generation BRSs?
15 Discussion
09:30 - 11:00 90 IPOP : Insight of Vulnerable Plaque
10/5 VP with Biomarker and Platelet Activity
10/5 IVUS and NIRS Assessment of VP
10/5 OCT Assessment of VP
10/5 VP and Endothelial Shear Stress
10/5 When and How to Treat VP
10/5 Intravascular OCT Imaging in Detection of Vulnerable Plaque
11:00 - 11:30 30 KSIC General Meeting
11:30 - 12:35 65 Clinical Controversies in TAVR: The Way to Overcome
12 TAVI in Korea: Lessons from Past Experiences and Future Direction
12 Reducing and Managing PVL
12 TAVR in Valve-in-Valve
12 Infective Endocarditis after TAVR: How To Treat?
17 Discussion
12:35 - 13:40 65 Luncheon Symposium 5
13:40 - 15:10 90 SFR : In-stent Restenosis - How to Prevent and How to Treat
13/5 CTO-ISR Lesion
13/5 Left Main Bifurcation ISR Lesion
13/5 ISR with Heavily Calcified Lesion
13/5 ISR with Neoatherosclerosis
13/5 ISR after BRS Implantation
15:10 - 16:40 90 PRG 2 : Debates
Debate 1. Which Drug Do You Prefer for ACS Patients?
10 Prasugrel
10 Ticagrelor
10 Discussion
Debate 2. How to Tailor Your Antiplatelet Therapy?
10 Platet Function Test Is the Best Strategy
10 Switching Is the Best Strategy
10 Discussion
Debate 3. Which Drug Do You Prefer for Long-term Treatment in ACS Patients?
10 P2Y12 Inhibitor
10 NOAC
10 Discussion
16:40 - Closing of Day 3
Presentation Arena
Time PT·DC(min) Contents, Discussant Moderator, Lecturer
08:00 - 09:30 90 K-CTO : Modern Antegrade Approach for CTO Intervention
12/3 TBD
12/3 When and How to Do Parallel Wire Technique
12/3 Use of IVUS for Successful Anterograde CTO PCI
12/3 Common Complication during Antegrade CTO Intervention (Tip and Trick)
12/3 TBD
12/3 DECISION CTO Trial, Right Decision?
09:30 - 11:00 90 K-VIS : Designing Endovascular Therapy (EVT) for PAD
13/5 Tips and Tricks in Interpreting Non-invasive Imaging
13/5 Selection of Puncture Site, Sheath, or Antegrade/Retrograde/Crossover Approaches
13/5 Selection of Wire, Supporting Catheter and Wiring Techniques
13/5 Selection of DEB, BMS, DES or Atherectomy Devices
13/5 Which Lesion Should We Consider Surgery or Hybrid Procedure?
11:00 - 11:30 30 KSIC General Meeting
11:30 - 12:35 65 Case Presentation 3 - Coronary
12:35 - 13:40 65 Luncheon Symposium 6
13:40 - 14:45 65 Case Presentation 4 - Coronary
14:45 - 15:45 60 KCTA Session 1 - In-depth Content about Bifurcation
15 Review of the Latest Clinical Outcome Data on Bifurcation Lesions
15 Summary of the Stepwise Procedure of Bifurcation Lesion
15 Treatment of Bifurcation Lesion using IVUS & FFR Modality
15 Discussion
15:45 - 16:40 50 KCTA Session 2 - Latest Insurance Issues and Case Reviews
15 The latest Insurance Update Reviews for Cath Room Procedures
15 Interesting Case I
15 Interesting Case II
10 Discussion
16:40 - Closing of Day 3